TRACON Pharmaceuticals Inc (TCON)
1.445
-0.08
(-5.56%)
USD |
NASDAQ |
May 17, 16:00
1.445
0.00 (0.00%)
After-Hours: 20:00
TRACON Pharmaceuticals Enterprise Value: -5.310M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | -5.310M |
| May 16, 2024 | -5.083M |
| May 15, 2024 | -4.878M |
| May 14, 2024 | -4.082M |
| May 13, 2024 | -3.968M |
| May 10, 2024 | -4.173M |
| May 09, 2024 | -4.400M |
| May 08, 2024 | -4.560M |
| May 07, 2024 | -4.423M |
| May 06, 2024 | -4.446M |
| May 03, 2024 | -4.332M |
| May 02, 2024 | -4.446M |
| May 01, 2024 | -4.673M |
| April 30, 2024 | -4.628M |
| April 29, 2024 | -4.299M |
| April 26, 2024 | -4.446M |
| April 25, 2024 | -4.491M |
| April 24, 2024 | -4.264M |
| April 23, 2024 | -4.355M |
| April 22, 2024 | -4.423M |
| April 19, 2024 | -4.105M |
| April 18, 2024 | -3.763M |
| April 17, 2024 | -3.354M |
| April 16, 2024 | -4.673M |
| April 15, 2024 | -4.469M |
| Date | Value |
|---|---|
| April 12, 2024 | -3.194M |
| April 11, 2024 | -2.671M |
| April 10, 2024 | -1.716M |
| April 09, 2024 | -0.9148M |
| April 08, 2024 | 0.1728M |
| April 05, 2024 | 3.053M |
| April 04, 2024 | 3.372M |
| April 03, 2024 | 1.424M |
| April 02, 2024 | 10.35M |
| April 01, 2024 | 10.15M |
| March 28, 2024 | 10.99M |
| March 27, 2024 | 10.10M |
| March 26, 2024 | 11.00M |
| March 25, 2024 | 12.37M |
| March 22, 2024 | 12.21M |
| March 21, 2024 | 11.32M |
| March 20, 2024 | 8.364M |
| March 19, 2024 | 9.160M |
| March 18, 2024 | 7.868M |
| March 15, 2024 | 8.50M |
| March 14, 2024 | 11.35M |
| March 13, 2024 | 20.15M |
| March 12, 2024 | 9.183M |
| March 11, 2024 | 4.632M |
| March 08, 2024 | 2.676M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-7.595M
Minimum
Jun 06 2019
149.07M
Maximum
Dec 31 2020
26.23M
Average
20.21M
Median
Dec 14 2021
Enterprise Value Benchmarks
| BioSig Technologies Inc | 18.32M |
| Revolution Medicines Inc | 4.799B |
| Perspective Therapeutics Inc | 817.27M |
| Electromed Inc | 130.07M |
| Xtant Medical Holdings Inc | 116.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.439M |
| Revenue (Quarterly) | 3.045M |
| Total Expenses (Quarterly) | 0.263M |
| EPS Diluted (Quarterly) | 0.40 |
| Profit Margin (Quarterly) | 14.42% |
| Earnings Yield | -349.7% |
| Normalized Earnings Yield | -409.61 |